Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis

Arthur F Kavanaugh; Philip J Mease; Juan Jesus Gomez-Reino; Adewale O Adebajo; Jurgen Wollenhaupt; Dafna D Gladman; Marla Hochfeld; Lichen L Teng; Georg Schett; Eric Lespessailles; Stephen Hall

doi:10.3899/jrheum.140647

Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis

Arthur F Kavanaugh, Philip J Mease, Juan Jesus Gomez-Reino, Adewale O Adebajo, Jurgen Wollenhaupt, Dafna D Gladman, Marla Hochfeld, Lichen L Teng, Georg Schett, Eric Lespessailles, Stephen Hall

Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

108 Citations (Scopus)

Original language	English
Pages (from-to)	479 - 488
Number of pages	10
Journal	The Journal of Rheumatology
Volume	42
Issue number	3
DOIs	https://doi.org/10.3899/jrheum.140647
Publication status	Published - 2015

Access to Document

10.3899/jrheum.140647

Cite this

Kavanaugh, A. F., Mease, P. J., Gomez-Reino, J. J., Adebajo, A. O., Wollenhaupt, J., Gladman, D. D., Hochfeld, M., Teng, L. L., Schett, G., Lespessailles, E., & Hall, S. (2015). Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis. The Journal of Rheumatology, 42(3), 479 - 488. https://doi.org/10.3899/jrheum.140647

Kavanaugh, Arthur F ; Mease, Philip J ; Gomez-Reino, Juan Jesus ; Adebajo, Adewale O ; Wollenhaupt, Jurgen ; Gladman, Dafna D ; Hochfeld, Marla ; Teng, Lichen L ; Schett, Georg ; Lespessailles, Eric ; Hall, Stephen. / Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis. In: The Journal of Rheumatology. 2015 ; Vol. 42, No. 3. pp. 479 - 488.

@article{149b282488fc41fda438d139a98445f0,

title = "Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis",

author = "Kavanaugh, {Arthur F} and Mease, {Philip J} and Gomez-Reino, {Juan Jesus} and Adebajo, {Adewale O} and Jurgen Wollenhaupt and Gladman, {Dafna D} and Marla Hochfeld and Teng, {Lichen L} and Georg Schett and Eric Lespessailles and Stephen Hall",

year = "2015",

doi = "10.3899/jrheum.140647",

language = "English",

volume = "42",

pages = "479 -- 488",

journal = "The Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "3",

}

Kavanaugh, AF, Mease, PJ, Gomez-Reino, JJ, Adebajo, AO, Wollenhaupt, J, Gladman, DD, Hochfeld, M, Teng, LL, Schett, G, Lespessailles, E & Hall, S 2015, 'Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis', The Journal of Rheumatology, vol. 42, no. 3, pp. 479 - 488. https://doi.org/10.3899/jrheum.140647

Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis. / Kavanaugh, Arthur F; Mease, Philip J; Gomez-Reino, Juan Jesus; Adebajo, Adewale O; Wollenhaupt, Jurgen; Gladman, Dafna D; Hochfeld, Marla; Teng, Lichen L; Schett, Georg; Lespessailles, Eric; Hall, Stephen.

In: The Journal of Rheumatology, Vol. 42, No. 3, 2015, p. 479 - 488.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis

AU - Kavanaugh, Arthur F

AU - Mease, Philip J

AU - Gomez-Reino, Juan Jesus

AU - Adebajo, Adewale O

AU - Wollenhaupt, Jurgen

AU - Gladman, Dafna D

AU - Hochfeld, Marla

AU - Teng, Lichen L

AU - Schett, Georg

AU - Lespessailles, Eric

AU - Hall, Stephen

PY - 2015

Y1 - 2015

UR - http://www.jrheum.org/content/42/3/479.full.pdf+html

U2 - 10.3899/jrheum.140647

DO - 10.3899/jrheum.140647

M3 - Article

VL - 42

SP - 479

EP - 488

JO - The Journal of Rheumatology

JF - The Journal of Rheumatology

SN - 0315-162X

IS - 3

ER -

Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis

Access to Document

Other files and links

Cite this